NTII OTC
Neurobiological Technologies, Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -0.0%
5Y: -98.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$26M
+78.5% ▲
5Y CAGR: +56.7%
Gross Profit
$26M
+80.1% ▲
5Y CAGR: +56.6%
Operating Income
$3M
+120.9% ▲
Net Income
$3M
+119.1% ▲
EPS (Diluted)
$0.12
+114.3% ▲
EBITDA
$3M
+119.7% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2004 | FY2005 | FY2006 | FY2007 | FY2008 |
|---|---|---|---|---|---|
| Revenue | $3M | $12M | $18M | $15M | $26M |
| YoY Growth | +11.2% | +298.1% | +43.2% | -16.5% | +78.5% |
| Cost of Revenue | $72K | $194K | $230K | $205K | $132K |
| Gross Profit | $3M | $12M | $17M | $15M | $26M |
| Gross Margin | 97.7% | 98.4% | 98.7% | 98.6% | 99.5% |
| R&D Expenses | $11M | $23M | $27M | $25M | $18M |
| SG&A Expenses | $5M | $6M | $6M | $7M | $5M |
| Operating Expenses | $28M | $40M | $33M | $31M | $23M |
| Operating Income | -$25M | -$28M | -$16M | -$17M | $3M |
| Operating Margin | -813.9% | -226.4% | -88.3% | -113.1% | 13.2% |
| Interest Expense | $0 | $0 | $0 | $2M | $0 |
| Income Before Tax | -$25M | -$28M | -$14M | -$16M | $3M |
| Tax Expense | $0 | $300K | $0 | $0 | $0 |
| Net Income | -$25M | -$28M | -$14M | -$16M | $3M |
| Net Margin | -805.9% | -225.6% | -79.9% | -110.6% | 11.9% |
| EPS (Diluted) | $-6.58 | $-6.86 | $-3.26 | $-0.84 | $0.12 |
| EBITDA | -$12M | -$16M | -$15M | -$16M | $3M |
| Shares Outstanding | 4M | 4M | 4M | 19M | 27M |